Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

ELOX Eloxx Pharmaceuticals Inc

3,82

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 01:00:00

Verzögert um 15 Minuten

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

Eloxx Pharmaceuticals (NASDAQ:ELOX)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Eloxx Pharmaceuticals Charts.

Eloxx Pharmaceuticals (NASDAQ:ELOX)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Eloxx Pharmaceuticals Charts.

News Eloxx Pharmaceuticals Inc

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Mittwoch 21 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Eloxx Pharmaceuticals Provides Pipeline and Financing Updates
Donnerstag 11 Juli 2024 (6 Monate vor) • GlobeNewswire Inc.

Eloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program Updates
Dienstag 16 April 2024 (8 Monate vor) • GlobeNewswire Inc.

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Montag 1 April 2024 (9 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 29 März 2024 (9 Monate vor) • Edgar (US Regulatory)

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Donnerstag 21 März 2024 (9 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 14 März 2024 (9 Monate vor) • Edgar (US Regulatory)

Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to license ZKN-013 for rare dermatological diseases
Mittwoch 13 März 2024 (9 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 26 Januar 2024 (11 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 26 Januar 2024 (11 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 26 Januar 2024 (11 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 26 Januar 2024 (11 Monate vor) • Edgar (US Regulatory)

Weitere Eloxx Pharmaceuticals Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen